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Selective Cdk4 Inhibitors
Cyclins and cyclin-dependent kinases (Cdks) play important roles in regulation of the cell cycle.
In particular, D-type cyclins, which have been shown to be amplified or over-expressed in
several tumour cells, associate with Cdk4/6 to activate their phosphorylation activity. Cyclin D-
Cdk4/6 complexes phosphorylate the retinoblastoma protein (pRB) and regulate the cell cycle
during G1/S transition. Loss of function or deletion of p16
ink4a (endogenous Cdk4/6 specific
inhibitor protein) frequently occurs in clinical cancer cells. Thus, selective Cdk4/6 inhibitors
should be useful as a new class of cytostatic antitumour agents. In order to overcome the
problem of selectivity for Cdk4/6 over the hundreds of homologous kinases in the superfamily,
specific amino acid residues were identified around the ATP binding pocket of Cdk4 by
comparing the amino acid sequences of 390 representative kinases. Subsequently, a chemical
library was designed using this information about the locations of these amino acid residues (A
novel approach for the development of selective Cdk4 inhibitors: Library design based on
locations of Cdk4 specific amino acid residues, Honma, T. et. al., J. Med. Chem., 44, (2001),
4628-4640).
A small library of 64 single analogues was prepared in solution. Evaluation of the library
compounds’ ability to inhibit Cdk4 was undertaken. One of the most potent isolated was (i)
which displayed an IC50 of 2.3 nM against D-Cdk4 and had excellent selectivity over Cdk1/2
(780-fold/190-fold respectively), and >430-fold selectivity over a range of kinases investigated.
This library design, based on the locations of amino acids around the ATP binding pocket and an
analysis of the binding mode of lead compounds, has enabled the authors to develop potent and
selective inhibitors of Cdk4 efficiently. The kinase superfamily consists of numerous kinases that
have a common folding pattern. Therefore, in general it is difficult to improve target kinase
selectivity with respect to all other kinases simultaneously. The approach described here should
be helpful for the development of specific kinase inhibitors more systematically and efficiently.
Antibacterial Agents
The rapid emergence of drug resistant pathogens emphasises the need for new classes of anti-
bacterial agents. Historically, new types of compounds have been identified from the diverse
pool of natural products, for which there are many proven clinically efficacious agents. Many
existing antibacterial drugs, such as the β-lactams penicillin and methicillin, act by direct
inhibition of one or more key steps in the metabolic pathway for synthesis of bacterial cell wall
peptidoglycan. Efforts have been made to identify cell wall active agents through screening and
deconvolution of mixture-based combinatorial libraries (The identification and characterisation
of hydrazinyl urea-based antibacterial agents through combinatorial chemistry, Wilson, L. J. et.
al., Bioorg. Med. Chem. Lett., 11, (2001), 1149-1152).
A library of 10,000 semi-carbazone compounds in mixtures of 100 was synthesised in solution.
The library was screened for inhibition of growth, bacterial histidine kinases and peptidoglycan
biosynthesis in whole cells of staphylococcus aureus. Active mixtures were deconvoluted and
resynthesised as single compounds. These were tested in a cell wall synthesis assay,
staphylococcus aureus (MI246), and against a panel of six gram-positive pathogens. One of the
most potent compounds isolated was (ii) which displayed an IC50 of 66 µM against cell wall and
an arithmetic mean MIC of 1.5 µM against the panel of six gram-positive organisms. This work
has provided new structural classes of compounds with antibacterial activity and could provide a
basis for future work in this area.
µ Opiate Ligands
Parallel synthesis and high-throughput screening, relying to varying degrees on molecular
modelling for library management, description, similarity evaluation and quantitative structure-
activity relationships, have led to a dramatic increase in throughput in the primary stages of drug
discovery. A generic hit-to-lead strategy, relying on the systematic generation and evaluation of
analogues around the parent hit compound has been reported (From hit to lead. Combining two
complementary methods for focused library design. Application to µ opiate ligands, Poulain, R.
et. al., J. Med. Chem., 44, (2001), 3378-3390).
The strategy used here makes a concerted use of two different analoging methods to cover
efficiently the structural space around hits. The first method is classical exploratory analoging
based on similar topology. The second method relies on algorithms for rapid generation of 3D
molecular fingerprints based on multiconformational models of candidate compounds, in
combination with similarity evaluation tools for the comparison of 3D fingerprints. To validate
experimentally this strategy, the authors have applied this to the search for potent µ opiate
ligands. A library of 294 single compounds was synthesised in solution. The library compounds
were screened at 10 µM for binding at the µ opiate human receptor. One of the most potent
compounds found was (iii) which possessed an IC50 value of 0.9 nM against the human µ ligand.
This work has shown that the two design methods indicated above may be used in parallel for the
elucidation of SAR, and the potent compounds discovered here may lay the foundation for
further work in this area.
Influenza Virus Fusion Inhibitors
Problematic winter outbreaks of influenza continue to emerge annually and are associated with
significant morbidity and, in certain populations, mortality. These annual epidemics are driven
by antigenic drift, a consequence of the poor fidelity of the influenza virus RNA polymerase,
whilst the far more insidious pandemics that occur less frequently but generally impose a much
greater disease burden, result from antigenic shift. Recently, a strategy of prophylaxis that
depends upon vaccination campaigns conducted just prior to the onset of the influenza season
has been implemented. However, the success of this approach is highly dependent upon an
ability to accurately predict the anticipated circulating virus several months in advance to
produce an appropriately effective vaccine. As part of an overall effort directed towards further
defining the fusion-inhibiting pharmacophore and identifying compounds with both increased
potency and inhibition of H3 influenza subtypes, exploration of structure-activity relationships
associated with the amine element of literature compound (iv), BMY-27709 (Luo, G.-X.,
Colonno, R., Krystal, M. Virology, 1996, 226, 66), which has been identified as an effective and
potent inhibitor of the H1 and H2 subtypes of influenza A virus strain (An approach to the
identification of potent inhibitors of influenza virus fusion using parallel synthesis methodology,
Deshpande, M. S. et. al., Bioorg. Med. Chem. Lett., 11, (2001), 2393-2396).
Two libraries giving a total of 418 single compounds were synthesised in solution. The libraries
were screened for inhibition of the H1 subtype of influenza A viruses that act by preventing the
pH-induced fusion process, thereby blocking viral entry into host cells. In a plaque-reduction
assay, the most potent inhibitor found from both libraries synthesised was (v) which possessed
an EC50 value of 0.02 µg/mL. This work has identified highly potent inhibitors of H1 influenza
fusion based on the lead BMY-27709 (iv) and may lay the foundation for further work to
improve potency in this series.
